Malayer J R, Gorski J
Department of Biochemistry, University of Wisconsin-Madison 53706, USA.
Mol Cell Endocrinol. 1995 Sep 22;113(2):145-54. doi: 10.1016/0303-7207(95)03624-g.
To determine whether the estrogen receptor (ER) has a role in the modification of chromatin structure, we developed cell lines to model discrete stages in the estrogen response. Each cell line carries a population of stably expressed papillomavirus-based minichromosomes containing the 5' flanking region of the rat prolactin gene. We examined ER effects at the distal enhancer domain of the rat prolactin promoter, using DNaseI to probe for alterations of the nucleoprotein complex. Within 1 h after the start of estrogen treatment, modifications in the chromatin state of the distal enhancer region were detected in a pituitary-derived, permissive cell line (GH3G1J). In rat-1 fibroblast cell lines that maintain the same stably expressed papillomavirus-based minichromosomes in the absence of ER or pituitary-specific transcription factors (Rat-1.2A2; non-permissive), no estrogen-induced modifications in the chromatin state were detected at 1 or 24 h. In rat-1 fibroblast cell lines that also contained ectopically expressed, functional ER (Rat-1 + ER.8A1), no estrogen-induced modifications in the chromatin state were detected at 1 h, but a 24 h a specific modification in the local structure was induced. These data support a model in which the ER interacts with chromatin to modify local structure in such a way as to induce a permissive state for interactions of transcription factors necessary for hormone-induced activation of gene transcription.
为了确定雌激素受体(ER)在染色质结构修饰中是否发挥作用,我们构建了细胞系以模拟雌激素反应的不同阶段。每个细胞系携带一群稳定表达的基于乳头瘤病毒的微型染色体,其中包含大鼠催乳素基因的5'侧翼区域。我们使用DNA酶I探测核蛋白复合物的变化,研究了ER在大鼠催乳素启动子远端增强子结构域的作用。在雌激素处理开始后的1小时内,在一种垂体来源的许可细胞系(GH3G1J)中检测到远端增强子区域染色质状态的改变。在缺乏ER或垂体特异性转录因子的情况下维持相同稳定表达的基于乳头瘤病毒微型染色体的大鼠-1成纤维细胞系(Rat-1.2A2;非许可型)中,在1小时或24小时均未检测到雌激素诱导的染色质状态改变。在同样异位表达功能性ER的大鼠-1成纤维细胞系(Rat-1 + ER.8A1)中,1小时未检测到雌激素诱导的染色质状态改变,但在24小时诱导了局部结构的特异性改变。这些数据支持一种模型,即ER与染色质相互作用以修饰局部结构,从而诱导激素诱导的基因转录激活所需转录因子相互作用的许可状态。